Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | ARKGARK Genomic Revolution ETF | VTIVanguard Morningstar Total Stock Market ETF |
|---|---|---|
| Market | USCboe BZX | USNYSE Arca |
| Issuer | ARK | Vanguard |
| Asset class | Equity · US | Equity · US |
| Expense ratio | 0.75%Expense ratio, filed 26 Nov 2025 | 0.03%Expense ratio, filed 28 Apr 2026 |
| Net assets | $1.6BAs of 31 Jul 2026 | $2.3TAs of 30 Jun 2026 |
| Holdings | 33As of 31 Jul 2026 | 3,546As of 30 Jun 2026 |
| 12-month distribution yield | No trailing yield | 1.05% |
| Distributions | None in 12 months | Quarterly$3.9490 in 12 months |
| Last price | $48.6520 Oct 2026, 20:00 UTC | $377.0920 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | ARKG | VTI |
|---|---|---|
| ARKG | Same fund | 1.6%at least |
| VTI | 1.6%at least | Same fund |
ARKG and VTI
- Weighted overlap
- 1.6%
- Holdings in common
- 21
- ARKG holdings also in VTI
- 65.6% by count
- VTI holdings also in ARKG
- 1.1% by count
| Holding | Weight in ARKG | Weight in VTI | Overlap | Matched by |
|---|---|---|---|---|
| ELI LILLY & COMPANYELI LILLY & COMPANY COM US5324571083 | 4.68% | 1.40% | 1.40% | ISIN |
| NATERA INCNATERA INC COM US6323071042 | 4.13% | 0.05% | 0.05% | ISIN |
| ILLUMINA INCILLUMINA INC COM US4523271090 | 4.74% | 0.03% | 0.03% | ISIN |
| GUARDANT HEALTH INCGUARDANT HEALTH INC COM US40131M1099 | 4.74% | 0.03% | 0.03% | ISIN |
| IONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INC COM US4622221004 | 1.77% | 0.02% | 0.02% | ISIN |
| TEMPUS AI INCTEMPUS AI INC CL A US88023B1035 | 6.56% | <0.01% | <0.01% | ISIN |
| TWIST BIOSCIENCE CORPTWIST BIOSCIENCE CORP COM US90184D1000 | 7.73% | <0.01% | <0.01% | ISIN |
| VERACYTE INCVERACYTE INC COM US92337F1075 | 2.55% | <0.01% | <0.01% | ISIN |
| 10X GENOMICS INC10X GENOMICS INC CL A COM US88025U1097 | 9.39% | <0.01% | <0.01% | ISIN |
| BEAM THERAPEUTICS INCBEAM THERAPEUTICS INC COM US07373V1052 | 3.78% | <0.01% | <0.01% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | ARKG | VTI |
|---|---|---|
| US dollar (USD) | 99.8% | 100.5% |